# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015988
Filing Date
2022-04-26
Accepted
2022-04-26 17:00:33
Documents
3
Period of Report
2022-06-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20003900x2_def14a.htm | DEF 14A | 687315
2 |  | ny20003900x2_pc01.jpg | GRAPHIC | 649380
3 |  | ny20003900x2_pc02.jpg | GRAPHIC | 355454
| Complete submission text file | 0001140361-22-015988.txt |  | 2071834

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-11460 | Film No.: 22855178
SIC: 2834 Pharmaceutical Preparations